(Q40551462)

21 September 2017

1 reference

title

Weight Loss Decreases Magnetic Resonance Elastography Estimated Liver Stiffness in Nonalcoholic Fatty Liver Disease (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

21 September 2017

1 reference

David Brenner

12

0 references

Bernd Schnabl

11

object named as

Bernd Schnabl

1 reference

21 September 2017

Niraj S Patel

1

1 reference

21 September 2017

Jonathan Hooker

2

1 reference

21 September 2017

Monica Gonzalez

3

1 reference

21 September 2017

Archana Bhatt

4

1 reference

21 September 2017

Phirum Nguyen

5

1 reference

21 September 2017

Kimberly Ramirez

6

1 reference

21 September 2017

Lisa Richards

7

1 reference

21 September 2017

Emily Rizo

8

1 reference

21 September 2017

Carolyn Hernandez

9

1 reference

21 September 2017

Tatiana Kisseleva

10

1 reference

21 September 2017

Claude B Sirlin

13

1 reference

21 September 2017

Rohit Loomba

14

1 reference

21 September 2017

language of work or name

English

0 references

publication date

3 October 2016

1 reference

Clinical Gastroenterology and Hepatology

21 September 2017

1 reference

21 September 2017

15

1 reference

21 September 2017

3

1 reference

21 September 2017

463-464

1 reference

Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study.

21 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5476292

Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5476292

Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5476292

Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5476292

Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5476292

The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5476292

Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5476292

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5476292

10.1016/J.CGH.2016.09.150

20 August 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference

21 September 2017

PubMed publication ID

27712981

1 reference